Honor promise of hepatitis treatment
Updated: 2016-07-30 07:42
By Bernhard Schwartlander(China Daily)
|
|||||||||
There is much to celebrate as China marked World Hepatitis Day this week. A large-scale immunization program has led to the current generation of Chinese children being virtually hepatitis B free. In the past year, major policy developments have paved the way for significantly easier access to treatment for both hepatitis B and C. Now, we need to translate the promise of better access to treatment into reality for all.
About 100 million people in China are still living with chronic hepatitis B or C infection. That is one in 13 people! And the majority are unaware of the fact, making hepatitis a truly "silent epidemic". Without treatment, up to one-third will develop life-threatening illnesses such as cirrhosis and liver cancer. All told, there will be about 10 million deaths among people living with chronic hepatitis B and C in the next 15 years.
Effective treatments for chronic hepatitis exist. There are now drugs available for hepatitis B infection that can reverse the damage to the liver and reduce the risk of liver cancer. For hepatitis C, direct-acting antiviral (DAA) medicines can actually cure the infection and get rid of the virus completely - with just a three-month course of treatment.
Yet only 1 in 50 people with hepatitis B or C in China are receiving the treatment they need. The biggest hindrance to hepatitis B treatment is the prohibitive cost, which is beyond the reach of people with average incomes. The cost can exceed 40 percent of the annual average household income, and the figure increases dramatically as the disease progresses.
For hepatitis C, the problem is not just one of cost. The DAA medicines which can cure almost everyone with hepatitis C in just 12 weeks are not available in China at all, because of complex and lengthy drug registration processes.
A person who needs treatment for hepatitis B now but can't afford it will end up costing the healthcare system much more in the future if he/she develops a liver disease. And once liver cancer develops, healthcare costs escalate dramatically. In other words, not providing treatment now results in substantial costs to the healthcare system later on. Chronic hepatitis destroys not only the liver, in doing so it devastates lives, breaks up families, and breaks the bank.
Conversely, providing affordable and universal coverage to optimal treatment and care will save individuals and society substantial costs over time.
Fortunately, in the past year two major policy developments in China have established the foundation upon which large-scale access to hepatitis treatment can be built. The first is the significant reduction in the cost of the drug used to treat hepatitis B to a more affordable level - about 490 yuan ($76.9) a month, down from 1,500 yuan. The challenge now is to make sure that hepatitis B treatment is fully included in health insurance schemes, so that people living with hepatitis can get the treatment and care that they urgently need without crippling out-of-pocket expenses.
The other major policy development is the unprecedented acceleration of the registration process for new hepatitis C medicines. On the surface, this is fantastic news. It simply isn't right that people living with hepatitis C in China can't access the best treatments readily available elsewhere in the world. But it is still not clear how long this accelerated process will take. So, people have to wait and suffer the consequences of hepatitis C infection in the meantime.
We have seen what China can do when it sets its mind to a task - the fact that hundreds of millions of Chinese children have been spared hepatitis infection through the immunization program is testament to this determination. Now is the time to apply the same approach to providing optimal and affordable treatment to those already afflicted with the disease. We simply cannot afford not to treat people with hepatitis. Only when people can actually get these medicines at an affordable price will lives be saved.
The author is World Health Organization representative in China.
(China Daily 07/30/2016 page5)
- S. Korea to launch WWII 'comfort women' victims foundation
- China to become Australia's biggest tourist source market
- Patient shoots, kills doctor in Berlin then kills himself
- One of church attackers tried to join IS in Syria
- China's coal usage may peak by 2020, experts say
- Bavarian bomber pledged allegiance to Islamic State
- In pictures: Aerial images of Rio's Olympic venues
- Images reveal distinctive Tunpu culture in Guizhou
- Ten photos from around China: July 22 – 28
- Welcome back, daddy!
- Sweat, hard work and pain: Life of model
- Top 10 most profitable companies in the world
- Exhibition showcases Chinese artworks in London
- In pics: Cool ways to beat the heat wave
Most Viewed
Editor's Picks
Anti-graft campaign targets poverty relief |
Cherry blossom signal arrival of spring |
In pictures: Destroying fake and shoddy products |
China's southernmost city to plant 500,000 trees |
Cavers make rare finds in Guangxi expedition |
Cutting hair for Longtaitou Festival |
Today's Top News
Ministry slams US-Korean THAAD deployment
Two police officers shot at protest in Dallas
Abe's blame game reveals his policies failing to get results
Ending wildlife trafficking must be policy priority in Asia
Effects of supply-side reform take time to be seen
Chinese State Councilor Yang Jiechi to meet Kerry
Chinese stocks surge on back of MSCI rumors
Liang avoids jail in shooting death
US Weekly
Geared to go |
The place to be |